Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
---|
01/12/2010 | CA2399062C Stereoselective synthesis of nucleoside analogues |
01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
01/07/2010 | WO2010001673A1 Manufacturing method for fluoropropylene carbonate |
01/07/2010 | WO2010000083A1 Isolongifolanyl-derivatives suitable as odorants |
01/07/2010 | US20100004470 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
01/07/2010 | US20100004444 Novel Triazolo pyrimidine compounds |
01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
01/06/2010 | EP1734603B1 Electrolyte material for polymer electrolyte fuel cells, electrolyte membrane and membrane- electrode assembly |
01/06/2010 | CN101622238A Method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal and process for producing the same |
01/06/2010 | CN100577037C Alkyldienamides exhibiting taste and sensory effect in flavor compositions |
01/05/2010 | US7642367 Diamino-functional chalcones |
01/05/2010 | US7641914 Acid-sensitive compounds, their preparation and uses |
01/05/2010 | CA2428255C Onium salts and the use therof as latent acids |
01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
01/05/2010 | CA2315635C Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same |
12/31/2009 | US20090326248 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
12/31/2009 | US20090326178 Method for Producing Fluorinated Compounds and Polymers |
12/31/2009 | US20090325962 Tyrosine derivative |
12/31/2009 | US20090325908 9-substituted minocycline compounds |
12/30/2009 | WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity |
12/30/2009 | WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
12/30/2009 | EP2137176A1 Process for preparing an 1,2-alkylene carbonate |
12/30/2009 | CN101613340A Hazel endothelin and extracting method and drug application thereof |
12/30/2009 | CN101613339A Method for synthesizing ethylene carbonate and catalyst therefor |
12/30/2009 | CN101613338A Preparation method of cyclic carbonate with joint product of ammonium hydrogen phosphate |
12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
12/30/2009 | CN100575330C Novel compounds |
12/29/2009 | CA2418829C Process for the preparation of baccatin iii derivatives |
12/29/2009 | CA2408914C Novel triazolo pyrimidine compounds |
12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
12/23/2009 | WO2009154154A1 Process for production of benzaldehyde compound |
12/23/2009 | EP2134675A2 Method for the co-production of cyclic carbonates and amino acids |
12/23/2009 | EP1817309B1 Acetamide compounds as fungicides |
12/23/2009 | CN101607954A Danshensu derivative, preparation method thereof, and application thereof in pharmacy |
12/23/2009 | CN101607904A Danshensu derivatives and synthesis method and application thereof |
12/23/2009 | CN101606929A Application of deoxypodophyllotoxin |
12/23/2009 | CN100572375C Spiro-benzodioxoles and their use as CB1 antagonists |
12/22/2009 | US7635780 Perfluoro-4-methyl-2-methylene-1,3-dioxolane, for example, prepared by reacting mixture of 2-chloro-1-propanol and 1-chloro-2-propanol with methyl trifluoropyruvate; useful as an optical or electrical materials |
12/22/2009 | US7635742 Modified isocyanates |
12/22/2009 | CA2451763C Process for the recovery of a polyol from an aqueous solution |
12/17/2009 | WO2009150248A1 Compounds which can be used for the treatment of cancers |
12/17/2009 | US20090312392 Amino ceramide-like compounds and therapeutic methods of use |
12/17/2009 | US20090311403 Method of Using Organic Compounds |
12/17/2009 | US20090311402 Alkyldienamides exhibiting taste and sensory effect in flavor compositions |
12/17/2009 | CA2727296A1 Compounds which can be used for the treatment of cancers |
12/16/2009 | EP1910260B1 Process for preparing 3,4-dioxo-substituted aromatic aldehydes |
12/16/2009 | CN101605774A 2-methyl-3-(3,4-methylenedioxyphenyl)propanal, and method for production thereof |
12/16/2009 | CN101602014A Load type carbon nano-fiber catalyst and application thereof |
12/16/2009 | CN100569766C Difluorobenzo-1,3-dioxoles |
12/15/2009 | US7632531 such as 2,6-nonadienamide,N-2-propenyl-,(2E,6Z); organoleptic; for addition to foods, beverages, medicine, and toothpaste |
12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
12/15/2009 | CA2342217C Process for producing stereoselective nitro compounds |
12/10/2009 | WO2009147632A2 New compounds for the treatment of cancer |
12/10/2009 | WO2009147217A1 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization |
12/10/2009 | WO2009123355A3 Cooling sensation agent composition and sensory stimulation agent composition |
12/10/2009 | US20090306408 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative |
12/10/2009 | US20090306109 Fungicide active substance combinations |
12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
12/10/2009 | US20090306022 7-substituted tetracycline compounds |
12/10/2009 | CA2726907A1 Dihydro-iso ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization |
12/09/2009 | EP2130583A1 Method for producing carbonyl compound |
12/09/2009 | EP2129654A1 Novel antagonists of the glucagon receptor |
12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
12/09/2009 | EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
12/09/2009 | CN101597275A Method for purifying fluoroethylene carbonate |
12/09/2009 | CN101597212A Kirenol derivative and application thereof in preparation of proinflammatory cytokine inhibitor |
12/08/2009 | US7629476 chemical intermediates; 2-chloromethyl-5,5-dimethyl-2-(2,5-dimethylphenyl)-[1,3]dioxane |
12/08/2009 | US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly |
12/08/2009 | US7629380 Antitumor agents |
12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
12/08/2009 | US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
12/08/2009 | CA2362695C Process for producing a fluorine-containing compound by liquid phase fluorination |
12/03/2009 | WO2009146202A2 Transketalized compositions, synthesis, and applications |
12/02/2009 | EP2128150A1 Fluorine-containing compound and fluorine-containing polymer |
12/02/2009 | EP2126574A2 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
12/02/2009 | CN101591327A Benzene alkyl amides compound and usage thereof |
12/02/2009 | CN101591326A Method for synthesizing 1,3-benzo-dioxolane compound |
12/02/2009 | CN101591226A 1,3-diarylpropane derivatives and application thereof |
12/01/2009 | US7626042 O-substituted hydroxyaryl derivatives |
12/01/2009 | CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
12/01/2009 | CA2170806C Tricyclic derivatives, process for preparing the same, their use for preparing optically active colchicine and thiocolchicine or racemates thereof, and analogs, derivatives and intermediates |
11/26/2009 | WO2009142184A1 Method of producing bicyclo[3.1.0]hexane derivative using enzyme |
11/26/2009 | WO2009141377A1 Process for preparing an 1,2-alkylene carbonate |
11/26/2009 | WO2009141361A2 Process for the production of alkylene carbonate |
11/26/2009 | WO2009035542A3 Guanidine-containing compounds useful as muscarinic receptor antagonists |
11/26/2009 | US20090292093 Fluorinated compound and fluorinated polymer |
11/26/2009 | US20090291998 Eponemycin and epoxomicin analogs and uses thereof |
11/26/2009 | US20090291958 Substituted PDE5 inhibitors |
11/26/2009 | US20090291923 Trioxane dimers having high anticancer and long-lasting antimalarial activities |
11/25/2009 | EP2123630A1 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
11/25/2009 | EP2121576A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
11/25/2009 | EP2120576A2 Aminoazoline and urea derivatives for combating animal pests |
11/25/2009 | EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides |
11/25/2009 | CN101587971A Electrolyte and lithium ion secondary battery comprising the same |
11/25/2009 | CN101584994A Catalyst and method for catalyzing and synthetizing carbon dioxide and epoxy compounds into cyclic carbonate |
11/24/2009 | US7622616 in the presence of a transition metals and immiscible solvents, to obtain vinyl compounds from halofluorinated compounds; by-product inhibition |
11/24/2009 | CA2418794C Calcium receptor antagonists |
11/24/2009 | CA2385882C Tyrosine derivatives |
11/19/2009 | WO2009140319A1 Process for the preparation of alkylene carbonate and/or alkylene glycol |